{
  "e_uid": "NIDA-CTO-0001",
  "studynum": "NIDA-CTO-0001",
  "investigator": "Eugene Somoza, M.D.",
  "study_title": "&nbsp;\n                    Phase 2, Double-Blind, Placebo-Controlled Trial Of Reserpine For The Treatment Of Cocaine Dependence",
  "release_date": "2014-12-04",
  "study_description": "The primary objective of this study is to assess the efficacy of reserpine in reducing cocaine use in subjects with cocaine dependence (DSM-IV criteria). The hypothesis is that reserpine will increase the weekly mean proportion of cocaine non-use days over the treatment period when compared to placebo as determined by self-report of cocaine use confirmed with urine assays for BE.",
  "keywords": "Reserpine, Phase 2B, Cocaine, Stimulant",
  "url": "https://datashare.nida.nih.gov/protocol/nida-cto-0001",
  "v_uid": "NIDA-CTO-0001",
  "v_uuid": "2ced4c1f-a89a-5044-b645-ec4f5f0db874",
  "v_lastmodified": ""
}
